Furthermore, NV-5297 treatment ameliorated MSN pathology in HD mice brains compared to vehicle-treated controls, as evidenced by increased DARPP-32 levels and greater striatal volume without MSN cell body enlargement. The gene discussed is PPP1R1B; the disease is Huntington disease.